Pharma's shift into emerging markets and away from established sales and marketing routines leads to permanent job cuts, says The Economist. That's in contrast to job cuts that normally accompany a recession, which are reversible when the economy improves. Jobs that are disappearing now will probably not reappear, but that may help save other jobs by shoring up pharma company profits. Article